» Authors » J I Sage

J I Sage

Explore the profile of J I Sage including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 411
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Golbe L, Lazzarini A, Spychala J, Johnson W, Stenroos E, Mark M, et al.
Mov Disord . 2001 Jun; 16(3):442-7. PMID: 11391737
Parkinson's disease (PD) is primarily an alpha-synucleinopathy, rather than a tauopathy, but there is evidence for an indirect association of tau with the pathogenetic process in PD. We therefore assessed...
2.
Menza M, Palermo B, DiPaola R, Sage J, Ricketts M
J Geriatr Psychiatry Neurol . 1999 Sep; 12(2):49-52. PMID: 10483924
Recently, a functional polymorphism in the promoter region of the serotonin transporter gene has been linked to anxiety. In cell culture, the short allele of this polymorphism synthesizes less serotonin...
3.
Hempel A, Wagner M, Maaty M, Sage J
Ann Pharmacother . 1998 Oct; 32(9):878-83. PMID: 9762373
Objective: To compare the costs of pharmacotherapy in patients with Parkinson's disease before and after converting from standard Sinemet to extended-release Sinemet CR. Design: Investigators retrospectively reviewed records of patients...
4.
Ricketts M, Hamer R, Manowitz P, Feng F, Sage J, Di Paola R, et al.
Clin Genet . 1998 Sep; 54(1):33-8. PMID: 9727737
The dopamine D4 receptor (D4DR) has a highly polymorphic region in the third exon which has been associated with novelty seeking (NS) behavior. Due to the central position of dopamine...
5.
Ricketts M, Hamer R, Sage J, Manowitz P, Feng F, Menza M
Psychiatr Genet . 1998 Aug; 8(2):41-4. PMID: 9686420
A polymorphic 44-nucleotide insertion/deletion in the promoter region of the serotonin transporter gene (5-HTTLPR) has been shown to affect the level of expression of the serotonin transporter protein. An association...
6.
Syed N, Murphy J, Zimmerman Jr T, Mark M, Sage J
Mov Disord . 1998 Apr; 13(2):336-8. PMID: 9539350
We report our long-term experience using enteral levodopa infusions in 22 patients with Parkinson's disease and severe motor fluctuations. Amelioration of intractable dyskinesias was the most important factor that determined...
7.
Hillen M, Sage J
Neurology . 1996 Nov; 47(5):1180-3. PMID: 8909426
We studied the nature and frequency of nonmotor "off" phenomena in 130 consecutive patients with Parkinson's disease (PD) with motor fluctuations. Twenty-two patients (17%) experienced nonmotor fluctuations as an end-of-dose...
8.
Wagner M, Fedak M, Sage J, Mark M
Ann Clin Lab Sci . 1996 Sep; 26(5):389-95. PMID: 8879356
The incidence of complications associated with disease and treatment was compared in younger versus elderly patients with Parkinson's disease (PD). One hundred sixty-five patient records were divided according to patient...
9.
Golbe L, Rubin R, Cody R, Belsh J, Duvoisin R, Grosmann C, et al.
Neurology . 1996 Jul; 47(1):148-54. PMID: 8710069
The cause of progressive supranuclear palsy (PSP) is not known and has been little studied. The one previous controlled epidemiologic survey, performed at our center in 1986, found small-town experience...
10.
Hillen M, Wagner M, Sage J
Arch Phys Med Rehabil . 1996 Jul; 77(7):710-2. PMID: 8670000
Objective: To investigate risk factors associated with subjective complaints of dizziness in 12 elderly patients with Parkinson disease (PD), in whom no obvious cause for this symptom could be found....